Publications en collaboration avec des chercheurs de Hospital Universitario Puerta de Hierro (21)

2023

  1. Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo

    JACC: Cardiovascular Imaging, Vol. 16, Núm. 12, pp. 1567-1580

2022

  1. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198

2021

  1. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764

  2. Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy

    European Journal of Heart Failure, Vol. 23, Núm. 8, pp. 1276-1286

2020

  1. A Contemporary Picture of Enterococcal Endocarditis

    Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494

  2. Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy

    Heart, Vol. 106, Núm. 17, pp. 1342-1348

  3. Premature ventricular contractions in patients with an implantable cardioverter defibrillator cardiac resynchronization therapy device: Results from the UMBRELLA registry: PVC in CRT-D patients

    Indian Pacing and Electrophysiology Journal, Vol. 20, Núm. 3, pp. 91-96

2019

  1. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

  2. Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices

    Journal of Interventional Cardiac Electrophysiology, Vol. 54, Núm. 3, pp. 267-275

  3. Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II)

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1020-1030

  4. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis

    International Journal of Cardiology, Vol. 274, pp. 163-169

2018

  1. Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse

    Journal of the American College of Cardiology, Vol. 71, Núm. 24, pp. 2731-2740

2017

  1. Association of cardiac resynchronization therapy with the incidence of appropriate implantable cardiac defibrillator therapies in ischaemic and non-ischaemic cardiomyopathy

    Europace, Vol. 19, Núm. 11, pp. 1818-1825

2016

  1. A multicentric study of long-term rhythm patterns in heart rate

    Computing in Cardiology

  2. An Automatic Algorithm Based on Morphological Stability During Fast Ventricular Arrhythmias Predicts Successful Antitachycardia Pacing in ICD Patients: A Multicenter Study

    PACE - Pacing and Clinical Electrophysiology, Vol. 39, Núm. 7, pp. 633-641

  3. Etiology and Programming Effects on Shock Efficacy in ICD Recipients

    PACE - Pacing and Clinical Electrophysiology, Vol. 39, Núm. 1, pp. 73-80

  4. Safety threshold of R-wave amplitudes in patients with implantable cardioverter defibrillator

    Heart, Vol. 102, Núm. 20, pp. 1662-1670

2015

  1. Shock Reduction with Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients with Implantable Cardioverter Defibrillators: A Multicenter Study

    Journal of Cardiovascular Electrophysiology, Vol. 26, Núm. 7, pp. 774-782

2014

  1. Perfil clínico e incidencia de arritmias ventriculares de los pacientes sometidos a recambio de generador de desfibrilador en España

    Revista Espanola de Cardiologia, Vol. 67, Núm. 12, pp. 986-992

2010

  1. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma

    Genes Chromosomes and Cancer, Vol. 49, Núm. 5, pp. 439-451